<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sopic M</submitter><funding>Regione Lombardia</funding><funding>Italian Ministry of Health</funding><funding>Telethon Foundation</funding><funding>British Heart Foundation</funding><funding>Ministry of Education, Science and Technological Development, Republic of Serbia</funding><funding>AFM-Telethon</funding><funding>Italian Cardiology Network IRCCS</funding><funding>Ministère de l&amp;apos;Enseignement Supérieur et de la Recherche</funding><funding>Alan Turing Institute</funding><funding>Ricerca Corrente - Rete cardiologica IRCCS</funding><funding>American Heart Association</funding><funding>Heart Foundation—Daniel Wagner of Luxembourg</funding><funding>EU Horizon 2020</funding><funding>Telethon</funding><funding>European Union</funding><funding>Fonds National de la Recherche Luxembourg</funding><funding>Colorado Clinical and Translational Sciences Institute</funding><funding>cardioRNA COST action</funding><funding>CardioRNA COST action</funding><pagination>16</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10158703</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>118(1)</volume><pubmed_abstract>The number of "omics" approaches is continuously growing. Among others, epigenetics has appeared as an attractive area of investigation by the cardiovascular research community, notably considering its association with disease development. Complex diseases such as cardiovascular diseases have to be tackled using methods integrating different omics levels, so called "multi-omics" approaches. These approaches combine and co-analyze different levels of disease regulation. In this review, we present and discuss the role of epigenetic mechanisms in regulating gene expression and provide an integrated view of how these mechanisms are interlinked and regulate the development of cardiac disease, with a particular attention to heart failure. We focus on DNA, histone, and RNA modifications, and discuss the current methods and tools used for data integration and analysis. Enhancing the knowledge of these regulatory mechanisms may lead to novel therapeutic approaches and biomarkers for precision healthcare and improved clinical outcomes.</pubmed_abstract><journal>Basic research in cardiology</journal><pubmed_title>Integration of epigenetic regulatory mechanisms in heart failure.</pubmed_title><pmcid>PMC10158703</pmcid><funding_grant_id>COVIRNA, Grant #101016072</funding_grant_id><funding_grant_id>RG/15/5/31446</funding_grant_id><funding_grant_id>Postdoctoral fellowship (#829504)</funding_grant_id><funding_grant_id>C17/BM/11613033</funding_grant_id><funding_grant_id>“Ricerca Corrente”,RF-2019-12368521</funding_grant_id><funding_grant_id>grants # C14/BM/8225223</funding_grant_id><funding_grant_id>RCR-2022-23682288</funding_grant_id><funding_grant_id>Network Development Award grant TNDC2-100022</funding_grant_id><funding_grant_id>&amp;quot;Progetto Immunhub&amp;quot;</funding_grant_id><funding_grant_id>Project COVIRNA (Grant # 101016072)</funding_grant_id><funding_grant_id>Pilot Grant award (#CO‐J‐22‐</funding_grant_id><funding_grant_id>#4462 GGP19035A</funding_grant_id><funding_grant_id>COVID-19/2020-1/14719577/miRCOVID</funding_grant_id><funding_grant_id>HORIZON-MSCA-2021-SE-01-01 - MSCA Staff Exchanges 2021 CardioSCOPE 101086397,HORIZON-MSCA-2021-PF- MAACS 101064175</funding_grant_id><funding_grant_id># 23054</funding_grant_id><funding_grant_id>Grant Agreement with University of Belgrade-Faculty of Pharmacy No: 451-03-9/2021-14/200161</funding_grant_id><funding_grant_id>GGP19035A</funding_grant_id><pubmed_authors>Sopic M</pubmed_authors><pubmed_authors>Emanueli C</pubmed_authors><pubmed_authors>Gaetano C</pubmed_authors><pubmed_authors>Angione C</pubmed_authors><pubmed_authors>Pedrazzini T</pubmed_authors><pubmed_authors>Devaux Y</pubmed_authors><pubmed_authors>Condorelli G</pubmed_authors><pubmed_authors>Martelli F</pubmed_authors><pubmed_authors>EU-CardioRNA COST Action CA17129 and EU-AtheroNET COST Action CA21153</pubmed_authors><pubmed_authors>Robinson EL</pubmed_authors><pubmed_authors>Srivastava P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Integration of epigenetic regulatory mechanisms in heart failure.</name><description>The number of "omics" approaches is continuously growing. Among others, epigenetics has appeared as an attractive area of investigation by the cardiovascular research community, notably considering its association with disease development. Complex diseases such as cardiovascular diseases have to be tackled using methods integrating different omics levels, so called "multi-omics" approaches. These approaches combine and co-analyze different levels of disease regulation. In this review, we present and discuss the role of epigenetic mechanisms in regulating gene expression and provide an integrated view of how these mechanisms are interlinked and regulate the development of cardiac disease, with a particular attention to heart failure. We focus on DNA, histone, and RNA modifications, and discuss the current methods and tools used for data integration and analysis. Enhancing the knowledge of these regulatory mechanisms may lead to novel therapeutic approaches and biomarkers for precision healthcare and improved clinical outcomes.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2024-11-09T22:41:02.798Z</modification><creation>2024-11-09T22:41:02.798Z</creation></dates><accession>S-EPMC10158703</accession><cross_references><pubmed>37140699</pubmed><doi>10.1007/s00395-023-00986-3</doi></cross_references></HashMap>